Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia Clinical Trials in Xi'an, Shannxi

Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia